Momenta Pharmaceuticals to Webcast Presentation at BioCentury's NewsMakers in the Biotech Industry Conference

CAMBRIDGE, Mass., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will present at the BioCentury NewsMakers in the Biotech Industry Conference on Friday, September 26 at 3:00 p.m. ET. Momenta will provide a company overview and program update, including comments on necuparanib (formerly M402), biosimilars and M356, the Company's generic version of Copaxone developed in collaboration with Sandoz.

The audio webcast of the presentation will be available live on the "Investors" section of the company's website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available for two weeks following the presentation.

About Momenta
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel products.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

CONTACT: Sarah Carmody Momenta Pharmaceuticals 1-617-395-5189 ir@momentapharma.comSource:Momenta Pharmaceuticals

More From Press Releases